The Pediatric Oncology Group of Ontario (POGO) welcomed a $100,000 donation from Bruce Power and its supplier partners.
"With pediatric childhood cancer types on the rise and not well understood, the Bruce Power and supplier donations enable POGO to continue to build the best childhood cancer research and care systems for impacted youth and their families," stated a release from Bruce Power.
POGO programs include financial assistance for families in need, transitions counselling and much needed continued research in the field.
“Through the generous commitment of Bruce Power and its supplier partners, we are making a meaningful difference in the childhood cancer community,” said Shannon Caskey, POGO’s Chief Development Officer. “Their investment enables us to extend our reach, innovate, and drive programs and services that benefit patients, survivors, families, and health care professionals throughout Ontario.”
Pat Dalzell, Bruce Power’s Vice-President of Corporate Affairs and Market Development, said the company and its partners are happy to be able to help.
“We are committed to supporting POGO with its impressive cancer care efforts. With cancer rates rising worldwide and its devastating impact on children and their families, we are proud to support an organization that provides impacted Ontario families with the care and comfort they need,” Dalzell said.
Bruce Power is a global supplier of medical isotopes used to treat various forms of cancer and in the sterilization of medical equipment.
Cobalt-60 from their reactors helps to sterilize 40 per cent of the world’s medical devices, battle cancer and treat brain tumours.
In 2022, Bruce Power installed an Isotope Production System to produce lutetium-177, which can help treat neuroendocrine tumours and prostate cancer. That system also has the capability of producing other cancer-fighting medical isotopes.
A second IPS will be added to Bruce Power’s Unit 7 this fall, doubling the amount of lutetium-177 Bruce Power supplies to the world’s health care sector.
